Phage therapy program
Severance Hospital — MP101 pneumonia trial
| Status | Official referral/inquiry route |
|---|---|
| Type | Center |
| Location | Seoul; South Korea |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | NCT07492771 lists Severance as Recruiting, actual start 2026-07-25, last update 2026-07-28. Study contact Jun Yong Choi: seran@yuhs.ac, +82 2 22281974; central sponsor contact Sangmin Lee smlee@microbiotix.net. This is trial eligibility screening, not a general clinic. |
|---|---|
| Areas of work | Phase1 adults with acute P. aeruginosa pneumonia; isolate must be susceptible to MP101 and not susceptible to current antibiotic therapy per protocol. |
| International access | Not stated in checked sources; do not infer eligibility from international collaborations. |
What to confirm
- Registry record inspected from root’s October 3 official API download (dataTimestamp 2026-10-02); record status is not a guarantee of available places.
- No general compassionate or international route verified.
Related studies(1)
MP101-1001
Recruiting
Recorded program–study link. Website
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | kr-severance-mp101 |
|---|